(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NYSE:ALNY) has seen a 4.82% increase in its short percent of float, now at 2.39% of all regular shares available for trading. This indicates a rise in bearish sentiment, although the company's short interest is still below the peer group average of 6.12%.
May 17, 2024 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alnylam Pharmaceuticals has experienced a 4.82% increase in short interest, now at 2.39% of its float. This rise in short interest suggests increased bearish sentiment, although it remains below the peer group average of 6.12%.
The increase in short interest indicates that more investors are betting against the stock, which could lead to downward pressure on the stock price in the short term. However, the short interest is still below the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100